Corrigendum to “Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration” [The Ocular Surface 30 (2023) 92-103]

Available online 28 January 2024

Author links open overlay panelFilippo Bonelli a b, Ibrahim Demirsoy a, Romina Mayra Lasagni Vitar a, Philippe Fonteyne a, Giulio Ferrari c dShow more

More from this channel

Corrigendum to “Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration” [The Ocular Surface 30 (2023) 92-103]

留言 (0)